Manufacturers Life Insurance Company, The Madrigal Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 24,080 shares of MDGL stock, worth $8.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,080
Previous 29,957
19.62%
Holding current value
$8.1 Million
Previous $6.36 Million
16.88%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$743 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$687 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$682 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$670 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$664 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.75B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...